News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
384,323 Results
Type
Article (31166)
Company Profile (50)
Press Release (353107)
Section
Business (112237)
Career Advice (1304)
Deals (23979)
Drug Delivery (80)
Drug Development (59299)
Employer Resources (100)
FDA (9757)
Job Trends (9041)
News (210195)
Policy (25396)
Tag
Academia (1827)
Africa (562)
Alliances (41905)
Alzheimer's disease (912)
Antibody-drug conjugate (ADC) (38)
Approvals (9707)
Arizona (55)
Artificial intelligence (47)
Asia (25131)
Australia (4513)
Bankruptcy (227)
Best Places to Work (7355)
Biosimilars (43)
Biotechnology (34)
C2C Services and Suppliers (31464)
California (844)
Canada (464)
Cancer (232)
Career advice (1092)
CAR-T (34)
Cell therapy (77)
China (63)
Clinical research (45947)
Collaboration (79)
COVID-19 (2365)
Cystic fibrosis (42)
Data (78)
Diabetes (50)
Diagnostics (3300)
Diversity, equity & inclusion (33)
Drug pricing (54)
Earnings (38583)
Employer resources (88)
Europe (60146)
Events (43496)
Executive appointments (31)
FDA (9844)
Florida (107)
Funding (43)
Gene therapy (61)
GLP-1 (488)
Government (3969)
Healthcare (11321)
Hotbed/Location (250613)
Illinois (110)
Indiana (75)
Infectious disease (2390)
Inflammatory bowel disease (57)
Interviews (227)
IPO (10228)
Job creations (1741)
Job search strategy (950)
Kansas (54)
Layoffs (229)
Legal (6965)
Liver cancer (38)
Lung cancer (49)
Manufacturing (65)
Maryland (224)
Massachusetts (634)
Medical device (5777)
Medtech (5778)
Mergers & acquisitions (13619)
Metabolic disorders (198)
Michigan (43)
Minnesota (56)
Neuroscience (994)
New Jersey (230)
New York (296)
NextGen Class of 2024 (3645)
Non-profit (2746)
North Carolina (253)
Northern California (430)
Obesity (125)
Ohio (54)
Opinion (161)
Patents (33)
Pennsylvania (272)
People (24098)
Phase I (13812)
Phase II (19956)
Phase III (16232)
Pipeline (63)
Policy (40)
Postmarket research (1831)
Preclinical (5755)
Rare diseases (68)
Real estate (2561)
Recruiting (41)
Regulatory (15218)
Research institute (1585)
Resumes & cover letters (194)
South America (788)
Southern California (358)
Startups (1869)
Texas (86)
United States (3736)
Vaccines (473)
Washington State (123)
Weight loss (120)
Date
Today (33)
Last 7 days (224)
Last 30 days (1706)
Last 365 days (23942)
2024 (15190)
2023 (25257)
2022 (33380)
2021 (35891)
2020 (34076)
2019 (27911)
2018 (21235)
2017 (20189)
2016 (18693)
2015 (21494)
2014 (15949)
2013 (12877)
2012 (13623)
2011 (14401)
2010 (13078)
384,323 Results for "medigene ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors
Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard) announces today that it has selected its lead candidate for MDG2021, a T cell receptor engineered T cell (TCR-T) therapy targeting Kirsten rat sarcoma viral oncogene homologue (KRAS) G12D with human leukocyte antigen (HLA)-A*11 being developed in combination with the Company’s PD1-41BB costimulatory switch protein (CSP) technology.
June 20, 2024
·
7 min read
Medigene AG reports Financial Results and Business Update for Q1 2024
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, reported financial results for the first quarter of 2024.
April 26, 2024
·
6 min read
Policy
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announced the submission of three patents to the European Patent Office.
May 28, 2024
·
4 min read
Medigene AG Secures European Patent for its iM-TCR Technology
Medigene AG announced that the Company has been issued a patent by the European Patent Office protecting its inducible Medigene T cell receptor technology, which contains a control mechanism to regulate efficacy and improve safety of its T cell receptor engineered T cell therapies.
April 4, 2024
·
4 min read
Business
Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update
Medigene AG reported financial results for the fiscal year ended December 31, 2023, and provided a corporate update.
March 28, 2024
·
8 min read
Medigene Reports Results of Annual General Meeting - June 24, 2024
Medigene AG, an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announces the results of the Annul General Meeting.
June 24, 2024
·
3 min read
Business
Medigene AG to report full year 2023 financial results on March 28, 2024
Medigene AG will report financial results and provide a corporate update for the fiscal year ended December 31, 2023, on Thursday, March 28, 2024.
March 18, 2024
·
1 min read
Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Medigene AG will be participating in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference on March 26, 2024.
March 19, 2024
·
1 min read
Press Releases
Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
August 14, 2024
·
8 min read
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
Medigene AG will present virtually at the 7th Cell and Gene Therapy In-Depth Focus Summit taking place from June 27-28, 2024, in Beijing, China.
June 21, 2024
·
2 min read
1 of 38,433
Next